Sanofi
Methods and compositions for treating subjects having rheumatoid arthritis
Last updated:
Abstract:
Disclosed herein are methods for treating subjects having rheumatoid arthritis (RA) with a human anti-interleukin 6 (IL-6) antibody, or antigen-binding portion thereof.
Status:
Grant
Type:
Utility
Filling date:
28 Aug 2019
Issue date:
3 May 2022